- Home
- MRNA vs PAA Comparison
MRNA vs PAA Comparison
Compare MRNA & PAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- PAA
- Stock Information
- Founded
- MRNA 2010
- PAA 1981
- Country
- MRNA United States
- PAA United States
- Employees
- MRNA N/A
- PAA N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- PAA Natural Gas Distribution
- Sector
- MRNA Health Care
- PAA Energy
- Exchange
- MRNA Nasdaq
- PAA Nasdaq
- Market Cap
- MRNA 9.2B
- PAA 12.1B
- IPO Year
- MRNA 2018
- PAA N/A
- Fundamental
- Price
- MRNA $24.36
- PAA $16.62
- Analyst Decision
- MRNA Hold
- PAA Hold
- Analyst Count
- MRNA 15
- PAA 12
- Target Price
- MRNA $36.69
- PAA $20.27
- AVG Volume (30 Days)
- MRNA 11.9M
- PAA 3.2M
- Earning Date
- MRNA 11-06-2025
- PAA 11-05-2025
- Dividend Yield
- MRNA N/A
- PAA 9.14%
- EPS Growth
- MRNA N/A
- PAA 7.88
- EPS
- MRNA N/A
- PAA 1.21
- Revenue
- MRNA $2,232,000,000.00
- PAA $46,917,000,000.00
- Revenue This Year
- MRNA N/A
- PAA N/A
- Revenue Next Year
- MRNA $10.38
- PAA $5.89
- P/E Ratio
- MRNA N/A
- PAA $16.11
- Revenue Growth
- MRNA N/A
- PAA N/A
- 52 Week Low
- MRNA $23.04
- PAA $15.58
- 52 Week High
- MRNA $56.70
- PAA $21.00
- Technical
- Relative Strength Index (RSI)
- MRNA 43.32
- PAA 49.28
- Support Level
- MRNA $23.48
- PAA $16.00
- Resistance Level
- MRNA $25.56
- PAA $16.76
- Average True Range (ATR)
- MRNA 1.46
- PAA 0.31
- MACD
- MRNA -0.32
- PAA 0.03
- Stochastic Oscillator
- MRNA 15.89
- PAA 52.59
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About PAA Plains All American Pipeline L.P.
Plains All American Pipeline LP through its subsidiaries, engages in the pipeline transportation, terminaling, storage, and gathering of crude oil and natural gas liquids (NGL) in the United States and Canada. The company operates through two segments, Crude Oil and NGL. The Crude Oil segment offers gathering and transporting crude oil through pipelines, gathering systems, trucks, and barges or railcars. The NGL segment is involved in natural gas processing and NGL fractionation, storage, transportation, and terminalling. It generates the majority of its revenue from the Crude Oil segment.